BioCentury
ARTICLE | Company News

DSM Biologics N.V., Nabi Biopharmaceuticals Inc. deal

July 5, 2004 7:00 AM UTC

NABI exercised its option to acquire exclusive worldwide distribution rights from DSM to Aloprim intravenous allopurinol. The compound is approved to control elevated uric acid levels in patients wit...